CHIMERIX INC Contracts & Agreements

Chimerix, Inc. Amended and Restated Officer and Severance Benefit Plan (Filed With SEC on November 14, 2024)

Chimerix, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on November 7, 2024)

Chimerix, Inc. 2024 Equity Incentive Plan (Filed With SEC on August 13, 2024)

Form of Stock Option Grant Notice and Option Agreement and Form of Restricted Stock Unit Award Agreement and Form of Restricted Stock Unit Awar (Filed With SEC on August 13, 2024)

Directorship Offer Letter to Marc D. Kozin, dated March 20, 2024 (Filed With SEC on May 1, 2024)

First Amendment to Loan and Security Agreement, dated November 21, 2023, by and between the Registrant and Silicon Valley Bank (Filed With SEC on February 29, 2024)

Open Market Sale AgreementSM dated February 29, 2024, by and between the Company and Jefferies LLC (Filed With SEC on February 29, 2024)

Directorship Offer Letter to Lisa L. Decker, PhD, dated December 28, 2023 (Filed With SEC on February 29, 2024)

Employment Offer Letter to Allen Melemed dated May 7, 2020 (Filed With SEC on March 2, 2023)

Description of Common Stock (Filed With SEC on March 2, 2023)

First Amendment to Asset Purchase Agreement, dated September 26, 2022, by and Between the Company, Emergent BioSolutions Inc. and Emergent Biodefense Operations Lansing LLC (Filed With SEC on September 28, 2022)

Asset Purchase Agreement, dated May 15, 2022, by and between the Company and Emergent BioSolutions Inc (Filed With SEC on May 18, 2022)

Chimerix, Inc.Officer Severance Benefit Plan (Filed With SEC on April 18, 2022)

Loan and Security Agreement, dated January 31, 2022, by and between the Registrant and Silicon Valley Bank (Filed With SEC on March 1, 2022)

Description of Common Stock (Filed With SEC on March 1, 2022)

Contract modification No. 66, dated May 24, 2021, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United States... (Filed With SEC on November 4, 2021)

Contract modification No. 67, dated September 20, 2021, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 4, 2021)

Contract modification No (Filed With SEC on May 6, 2021)

Contract modification No. 64, dated January 26, 2021 to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on February 25, 2021)

Underwriting Agreement, dated January 20, 2021, by and among Chimerix, Inc. and Jefferies LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on January 21, 2021)

Agreement and Plan of Merger, dated January 7, 2021, by and among the Company, Oncoceutics, Merger Sub and Fortis Advisors, LLC solely in its capacity as Securityholders... (Filed With SEC on January 13, 2021)

Promissory Note, dated January 7, 2021, by and between the Company and Fortis Advisors, LLC, solely in its capacity as Securityholders Representative (Filed With SEC on January 13, 2021)

Amendment to the Supply Agreement, dated December 16, 2020, by and between Chimerix, Inc. and Scientific Protein Laboratories, LLC (Filed With SEC on December 23, 2020)

Contract modification No. 62, dated September 11, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 5, 2020)

Contract modification No. 63, dated September 28, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 5, 2020)

Contract modification No. 28, dated September 1, 2015, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 5, 2020)

Contract modification No. 29, dated September 11, 2015, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 5, 2020)

Open Market Sale Agreement (Filed With SEC on August 10, 2020)

Contract modification No. 59, dated May 11, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United States... (Filed With SEC on August 10, 2020)

Contract modification No. 60, dated June 17, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on August 10, 2020)

Contract modification No. 61, dated July 28, 2020, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on August 10, 2020)

Ninth Amendment to Office Lease, dated June 24, 2020, by and between the Registrant and BRI 1875 Meridian, LLC (Filed With SEC on August 10, 2020)

Second Amendment to Lease Agreement, dated July 30, 2020, by and between the Registrant and CLPF-Research Center, LLC (Filed With SEC on August 10, 2020)

Chimerix, Inc. Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2020)

Contract modification No. 58, dated December 13, 2019, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on February 25, 2020)

License and Development Agreement, dated July 26, 2019, by and between the Registrant and Cantex Pharmaceuticals, Inc (Filed With SEC on November 5, 2019)

Supply Agreement, dated October 2, 2015, by and between the Registrant (as successor to Cantex Pharmaceuticals, Inc.) and Scientific Protein Laboratories LLC (Filed With SEC on November 5, 2019)

License Agreement, dated September 30, 2019, by and between the Registrant and SymBio Pharmaceuticals Limited (Filed With SEC on November 5, 2019)

Agreement and Release, dated June 6, 2019, by and between the Registrant and Timothy W. Trost (Filed With SEC on August 8, 2019)

Contract modification No. 57, dated July 12, 2019, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on August 8, 2019)

Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise for Inducement Grant Outside of 2013 Equity Incentive Plan (Filed With SEC on August 8, 2019)

Investors Rights Agreement between Chimerix, Inc. and Cantex Pharmaceuticals, Inc., dated July 26, 2019 (Filed With SEC on July 31, 2019)

Contract modification No. 56, dated March 5, 2019, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on May 9, 2019)

Contract modification No. 54, dated December 3, 2018, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on March 5, 2019)

Contract modification No. 55, dated January 10, 2019, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on March 5, 2019)

Agreement and Release, dated February 8, 2019, by and between the Registrant and M. Michelle Berrey (Filed With SEC on March 5, 2019)

Employment Offer Letter to Michael A. Alrutz dated May 9, 2012 (Filed With SEC on March 5, 2019)

Contract modification No. 53, dated September 6, 2018, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on November 8, 2018)

Chimerix, Inc. Officer Severance Benefit Plan, as amended (Filed With SEC on November 8, 2018)

Contract modification No. 51, dated May 31, 2018, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United States... (Filed With SEC on August 8, 2018)

Contract modification No. 52, dated July 11, 2018, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on August 8, 2018)

Non-Employee Director Compensation Policy of the Registrant (Filed With SEC on August 8, 2018)

Fifth Amendment, dated April 24, 2018, to the License Agreement by and between the Registrant and The Regents of the University of California dated May 13, 2002, as amended (Filed With SEC on May 7, 2018)

Contract modification No. 50, dated March 20, 2018, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on May 7, 2018)

Contract modification No. 45, dated October 20, 2017, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on March 1, 2018)

Contract modification No. 46, dated November 27, 2017, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on March 1, 2018)

Contract modification No. 47, dated December 21, 2017, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on March 1, 2018)

Contract modification No. 48, dated December 21, 2017, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on March 1, 2018)

Contract modification No. 49, dated February 27, 2018, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on March 1, 2018)

First Amendment to Lab Lease dated December 14, 2017 by and between Registrant and CLPF - Research Center, LLC (Filed With SEC on March 1, 2018)

Contract modification No. 38, dated April 3, 2017, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on August 7, 2017)

Contract modification No. 39, dated May 11, 2017, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United States... (Filed With SEC on August 7, 2017)

Contract modification No. 40, dated June 16, 2017, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on August 7, 2017)

Eighth Amendment to Office Lease dated July 14, 2017 by and between the Registrant and IVC Meridian TT O, LLC (Filed With SEC on August 7, 2017)

Non-Employee Director Compensation Policy of the Registrant (Filed With SEC on August 7, 2017)

Contract modification No. 37, dated March 27, 2017, to the contract by and between the Registrant and the Biomedical Advanced Research and Development Authority of the United... (Filed With SEC on May 9, 2017)

Seventh Amendment to Office Lease dated March 10, 2017 by and between the Registrant and IVC Meridian TT O, LLC (Filed With SEC on May 9, 2017)

CHIMERIX, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY LAST MODIFIED: MARCH 29, 2016 (Filed With SEC on March 2, 2017)

PATENT OPTION AND LICENSE AGREEMENT (Filed With SEC on March 2, 2017)

CHIMERIX, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on November 7, 2016)

3,775,000 Shares CHIMERIX, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on June 11, 2015)

SIXTH AMENDMENT TO OFFICE LEASE (Filed With SEC on May 11, 2015)

AMENDMENT NO. 1 TO SEVERANCE AGREEMENTAND RELEASE (Filed With SEC on November 7, 2014)

(Signature of Contracting Officer) (Filed With SEC on November 7, 2014)

FIFTH AMENDMENT TOOFFICE LEASE (Filed With SEC on November 7, 2014)

CHIMERIX,INC. AMENDMENT TO AMENDED AND RESTATEDINVESTOR RIGHTS AGREEMENT (Filed With SEC on November 7, 2014)

3,650,000 Shares CHIMERIX, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on October 31, 2014)

7,300,000 Shares CHIMERIX, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on May 21, 2014)

SeveranceAgreement and RELEASE (Filed With SEC on May 9, 2014)

ADDENDUM TO LEASE (Filed With SEC on May 9, 2014)

Chimerix,Inc. Non-EmployeeDirector Compensation Policy LastModified: December 6, 20131 (Filed With SEC on March 7, 2014)

Chimerix,Inc. OfficerSeverance Benefit Plan Approvedby the Board of Directors: February 21, 2013 Amendedby the Board of Directors: December 6, 2013 (Filed With SEC on March 7, 2014)

WITNESSETH: (Filed With SEC on March 7, 2014)

/s/EthanJ. Mueller (Signature of Contracting Officer) (Filed With SEC on March 7, 2014)

(Signature of Contracting Officer) (Filed With SEC on March 7, 2014)

FirstLOAN MODIFICATION AGREEMENT (Filed With SEC on March 7, 2014)

[] Shares CHIMERIX, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on October 17, 2013)

[·] Shares CHIMERIX, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on October 8, 2013)

(Signature of Contracting Officer) (Filed With SEC on August 14, 2013)

[·]Shares CHIMERIX, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on March 27, 2013)

Chimerix,Inc. 2002Equity Incentive Plan Adopted:September 27, 2002 ApprovedBy Stockholders: October 22, 2002 Amended:July 18, 2003 AmendmentApproved by Stockholders: July 18, 2003... (Filed With SEC on March 27, 2013)

Chimerix,Inc. 2012Equity Incentive Plan Adoptedby the Board of Directors: February 16, 2012 Approvedby the Stockholders: February 22, 2012 TerminationDate: February 15, 2022 (Filed With SEC on March 27, 2013)

Chimerix,Inc. 2013Equity Incentive Plan Adoptedby the Board of Directors: February 21, 2013 Approvedby the Stockholders: _________, 2013 IPODate/Effective Date: _________, 2013 (Filed With SEC on March 27, 2013)

Chimerix,Inc. 2013Employee Stock Purchase Plan Adopted by the Board of Directors: February 21, 2013 Approved by the Stockholders: ___________, 2013 (Filed With SEC on March 27, 2013)

CHIMERIX,INC. WARRANT TO PURCHASE STOCK (Filed With SEC on March 8, 2013)

WARRANT TO PURCHASE STOCK (Filed With SEC on March 8, 2013)

Exhibit A DISCLOSURE SCHEDULE (Filed With SEC on March 8, 2013)

amendedand restated INVESTOR RIGHTS AGREEMENT (Filed With SEC on March 8, 2013)

INDEMNITY AGREEMENT (Filed With SEC on March 8, 2013)

Chimerix,Inc. 2002Equity Incentive Plan Adopted:September 27, 2002 ApprovedBy Stockholders: October 22, 2002 Amended:July 18, 2003 AmendmentApproved by Stockholders: July 18, 2003... (Filed With SEC on March 8, 2013)

Chimerix,Inc. 2012Equity Incentive Plan Adoptedby the Board of Directors: February 16, 2012 Approvedby the Stockholders: February 22, 2012 TerminationDate: February 15, 2022 (Filed With SEC on March 8, 2013)

Chimerix,Inc. 2013Equity Incentive Plan Adoptedby the Board of Directors: February 21, 2013 Approvedby the Stockholders: _________, 2013 IPODate/Effective Date: _________, 2013 (Filed With SEC on March 8, 2013)

Chimerix,Inc. 2013Employee Stock Purchase Plan Adopted by the Board of Directors: February 21, 2013 Approved by the Stockholders: ___________, 2013 (Filed With SEC on March 8, 2013)

Non-EmployeeDirector Compensation Policy (Filed With SEC on March 8, 2013)

Chimerix,Inc. OfficerChange in Control Severance Benefit Plan (Filed With SEC on March 8, 2013)

Exhibit A IndemnificationAgreement (Filed With SEC on March 8, 2013)

ExhibitA (Filed With SEC on March 8, 2013)

2505Meridian Parkway, Suite 340 ŸDurham, NC 27713 Ÿ Phone ###-###-#### ŸFax ###-###-#### (Filed With SEC on March 8, 2013)

2505Meridian Parkway, Suite 340 ·Durham, NC 27713 ·Phone ###-###-#### ·Fax ###-###-#### (Filed With SEC on March 8, 2013)

CONSULTING AGREEMENT (Filed With SEC on March 8, 2013)

2505Meridian Parkway, Suite 340 ·Durham, NC 27713 ·Phone ###-###-#### ·Fax ###-###-#### (Filed With SEC on March 8, 2013)

OFFICE LEASE WITH Chimerix, Inc. (Filed With SEC on March 8, 2013)

LEASE AGREEMENT (Filed With SEC on March 8, 2013)

DEED OF SUBLEASE AGREEMENT (Filed With SEC on March 8, 2013)

COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT by and between MERCK SHARP & DOHME CORP. and CHIMERIX, INC. (Filed With SEC on March 8, 2013)

Category

Industry

Companies

Contracts

CHIMERIX INC Contracts & Agreements